| Application number | Title of the application | Filing Date | Status |
|---|
| 10/009134 | Methods and compositions for inhibiting the function of polynucleotide sequence | Oct 19, 2002 | Abandoned |
Array
(
[id] => 6730162
[patent_doc_number] => 20030186352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Apicomplexan chorismate synthase sequences and an inhibitor of the shikimate pathway'
[patent_app_type] => new
[patent_app_number] => 10/268611
[patent_app_country] => US
[patent_app_date] => 2002-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 42961
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186352.pdf
[firstpage_image] =>[orig_patent_app_number] => 10268611
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/268611 | Apicomplexan chorismate synthase sequences and an inhibitor of the shikimate pathway | Oct 9, 2002 | Abandoned |
Array
(
[id] => 7083831
[patent_doc_number] => 20050049211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Antisense modulation of insulin-like growth factor binding protein 5 expression'
[patent_app_type] => utility
[patent_app_number] => 10/491712
[patent_app_country] => US
[patent_app_date] => 2002-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25807
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049211.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491712
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491712 | Antisense modulation of insulin-like growth factor binding protein 5 expression | Oct 6, 2002 | Abandoned |
| 10/031308 | Oligonucleotides for metabotropic glutamate receptor type 1 (mglur1 | Sep 25, 2002 | Abandoned |
Array
(
[id] => 6730075
[patent_doc_number] => 20030186265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cord'
[patent_app_type] => new
[patent_app_number] => 10/254905
[patent_app_country] => US
[patent_app_date] => 2002-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 45047
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186265.pdf
[firstpage_image] =>[orig_patent_app_number] => 10254905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/254905 | Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cord | Sep 24, 2002 | Abandoned |
Array
(
[id] => 6711142
[patent_doc_number] => 20030170891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)'
[patent_app_type] => new
[patent_app_number] => 10/251117
[patent_app_country] => US
[patent_app_date] => 2002-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 42909
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170891.pdf
[firstpage_image] =>[orig_patent_app_number] => 10251117
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/251117 | RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA) | Sep 18, 2002 | Abandoned |
Array
(
[id] => 6861658
[patent_doc_number] => 20030092666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Compositions and methods for nucleic acid delivery to the lung'
[patent_app_type] => new
[patent_app_number] => 10/245722
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7005
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245722
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245722 | Compositions and methods for nucleic acid delivery to the lung | Sep 17, 2002 | Abandoned |
Array
(
[id] => 7075257
[patent_doc_number] => 20050148525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Obesity related genes expressed at least in the hypothalamus, liver or pancreas'
[patent_app_type] => utility
[patent_app_number] => 10/488350
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23551
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488350
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488350 | Obesity related genes expressed at least in the hypothalamus, liver or pancreas | Aug 27, 2002 | Abandoned |
| 10/070798 | Antisense modulation of pI3 kinase p110 beta expression | Aug 21, 2002 | Abandoned |
Array
(
[id] => 6809530
[patent_doc_number] => 20030199469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Combination of bryostatin and paclitaxel for treating cancer'
[patent_app_type] => new
[patent_app_number] => 10/215178
[patent_app_country] => US
[patent_app_date] => 2002-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 47606
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199469.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215178
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215178 | Combination of bryostatin and paclitaxel for treating cancer | Aug 6, 2002 | Issued |
| 10/070789 | Antisense modulation of x -linked inhibitor of apoptosis expression | Aug 5, 2002 | Abandoned |
Array
(
[id] => 7206733
[patent_doc_number] => 20040087523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Antisense modulation of cyclin-dependent kinase 6 expression'
[patent_app_type] => new
[patent_app_number] => 10/210802
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32874
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20040087523.pdf
[firstpage_image] =>[orig_patent_app_number] => 10210802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/210802 | Antisense modulation of cyclin-dependent kinase 6 expression | Jul 30, 2002 | Abandoned |
Array
(
[id] => 7400016
[patent_doc_number] => 20040023378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Antisense modulation of KIAA1531 protein expression'
[patent_app_type] => new
[patent_app_number] => 10/210290
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30612
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023378.pdf
[firstpage_image] =>[orig_patent_app_number] => 10210290
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/210290 | Antisense modulation of KIAA1531 protein expression | Jul 30, 2002 | Abandoned |
Array
(
[id] => 7401031
[patent_doc_number] => 20040019001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA'
[patent_app_type] => new
[patent_app_number] => 10/206705
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 33582
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20040019001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10206705
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/206705 | RNA interference mediated inhibition of protein typrosine phosphatase-1B (PTP-1B) gene expression using short interfering RNA | Jul 25, 2002 | Abandoned |
Array
(
[id] => 6865109
[patent_doc_number] => 20030190635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'RNA interference mediated treatment of Alzheimer\'s disease using short interfering RNA'
[patent_app_type] => new
[patent_app_number] => 10/205309
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 34803
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190635.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205309
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205309 | RNA interference mediated treatment of Alzheimer's disease using short interfering RNA | Jul 24, 2002 | Abandoned |
Array
(
[id] => 7448839
[patent_doc_number] => 20040009935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Antisense modulation of p21-activated kinase 2 expression'
[patent_app_type] => new
[patent_app_number] => 10/189406
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31347
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10189406
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/189406 | Antisense modulation of p21-activated kinase 2 expression | Jul 2, 2002 | Abandoned |
Array
(
[id] => 6851001
[patent_doc_number] => 20030143204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Inhibition of RNA function by delivery of inhibitors to animal cells'
[patent_app_type] => new
[patent_app_number] => 10/186757
[patent_app_country] => US
[patent_app_date] => 2002-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18149
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143204.pdf
[firstpage_image] =>[orig_patent_app_number] => 10186757
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/186757 | Inhibition of RNA function by delivery of inhibitors to animal cells | Jun 30, 2002 | Abandoned |
Array
(
[id] => 7011386
[patent_doc_number] => 20050065102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Medicinal compositions'
[patent_app_type] => utility
[patent_app_number] => 10/482103
[patent_app_country] => US
[patent_app_date] => 2002-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 21749
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20050065102.pdf
[firstpage_image] =>[orig_patent_app_number] => 10482103
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/482103 | Medicinal compositions | Jun 26, 2002 | Abandoned |
| 10/018227 | Antisense modulation of ets-2 expression | Jun 23, 2002 | Abandoned |
Array
(
[id] => 6809528
[patent_doc_number] => 20030199467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Antisense modulation of human Rho family gene expression'
[patent_app_type] => new
[patent_app_number] => 10/178325
[patent_app_country] => US
[patent_app_date] => 2002-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25078
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10178325
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/178325 | Antisense modulation of human Rho family gene expression | Jun 20, 2002 | Abandoned |
